When are MRI indications in breast cancer screening beyond standard population screening?

• A. MRI is indicated for high-risk individuals (e.g., BRCA mutation carriers, strong family history), supplemental screening in dense breasts, and problem-solving in known disease or implant patients to assess extent and implants
• B. MRI is only used for routine population screening
• C. MRI should replace mammography in all cases
• D. MRI is contraindicated in all patients with implants

Answer: (A)

MRI is used beyond routine population screening whenever a person’s situation makes the cancer harder to detect with standard mammography alone. In individuals at high risk (like BRCA mutation carriers or those with a strong family history), MRI adds sensitivity and is commonly used alongside or after mammography to catch cancers earlier. In women with dense breast tissue, MRI serves as supplemental screening because dense tissue can obscure tumors on mammograms, so MRI can reveal cancers that mammography might miss.

MRI also plays a problem‑solving role in people with known disease or implants. For someone with breast cancer, MRI helps map the full extent of the disease, detect multifocal or contralateral lesions, and aid surgical planning. For implant patients, MRI is not contraindicated; it can be used to assess implant integrity and to evaluate the surrounding breast tissue when needed.

Overall, MRI is not for routine population screening but is valuable in these specific scenarios to improve detection and guide management.